Halper Sadeh LLC Encourages PCH, COMP, RYN, HOUS Shareholders to Contact the Firm to Discuss Their Rights

(NASDAQ:PCH),(NYSE:COMP),(NYSE:RYN),(NYSE:HOUS), NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: PotlatchDeltic Corporation (NASDAQ: PCH)'s sale to Rayonier Inc. for 1.7339 common shares of Rayonier for each […]

Greenway Technologies Announces Appointments of Doug Cogan and C. Dunham Biles

(Other OTC:GWTI),(OTC US:GWTI), ARLINGTON, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) — Greenway Technologies, Inc. (OTCQB: GWTI) (“Greenway”), an advanced gas-to-liquids (“GTL”) and gas-to-hydrogen (“GTH”) technology development company, announced today that it has appointed Doug Cogan to serve as the Chief Executive Officer of the Company. Additionally, the Company appointed Mr. Doug Cogan and Mr. C.

Greenway Technologies Announces Appointments of Doug Cogan and C. Dunham Biles

Greenway Technologies Announces Appointments of Doug Cogan and C. Dunham Biles GlobeNewswire December 10, 2025 ARLINGTON, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) — Greenway Technologies, Inc. (OTCQB: GWTI) (“Greenway”), an advanced gas-to-liquids (“GTL”) and gas-to-hydrogen (“GTH”) technology development company, announced today that it has appointed Doug Cogan to serve as the Chief Executive Officer of

Privo Technologies Begins Dosing PRV131 in Arm 3 Of Clinical Study CLN-004, A First-In-Class Cisplatin Intratumoral Injectable Targeting Oral Cavity Cancer

Key Highlights: — First-in-human milestone: The inaugural patient has been dosed with PRV131. — Precise, localized delivery: Built on Privo's PRV Platform technology, PRV131 delivers high concentrations of cisplatin directly to tumors, while minimizing systemic exposure. Privo Technologies, Inc., today announced that the first patient has been dosed in its first-in-human clinical trial evaluating PRV131,

KEYCORP LOWERS ITS PRIME LENDING RATE TO 6.75 PERCENT

KeyCorp (NYSE: KEY) and its banking affiliates have lowered their prime lending rate to 6.75 percent from 7.00 percent, effective tomorrow, Dec. 11, 2025. About KeyCorp In 2025, KeyCorp celebrates its bicentennial, marking 200 years of service to clients and communities from Maine to Alaska. To learn more, visit KeyBank Heritage Center. Headquartered in Cleveland,

DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)

(NASDAQ:DXCM), RADNOR, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025,

DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)

DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM) GlobeNewswire December 10, 2025 RADNOR, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM)

Scroll to Top